How should corticosteroids be used in inflammatory bowel disease?

Clinical Immunotherapeutics

Volumn 5, Issue 5, 1996, Pages 334-340

  D'Haens, Geert R ^a   Rutgeerts, Paul J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TIXOCORTOL PIVALATE;

ANOREXIA; ARTHRALGIA; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; FEVER; GROWTH RETARDATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION; ULCERATIVE COLITIS;

EID: 0029978929     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259331     Document Type: Review

References (27)

1. Halvorsen S, Myren ), Aakvaag A. On the absorption of prednisone and prednisolone disodium phosphate after rectal ad ministration. Scand i Gastroenterol 1969; 4: 851
2. Matts S, Gaskell G. Rétrograde colonie spread of enemata in ulcerative colitis. BMJ 1961 ; 2: 614-6
3. Brattsand R. Overview of newer glucocorticosteroid preparations for inflammatory bowel disease. Can J Gastroenterol 1990; 4:407-14
4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955; 2: 1041-8
5. Baron JH, Connell AM, Kanaghinis TG, et al. Outpatient treatment of ulcerative colitis. BMJ 1967; 2: 441-3
6. Powell-Tuck J, Brown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978; 13: 833-7
7. Truelove SC, Lee EG, Willoughby CP, et al. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978; II: 1086-8
8. Lennard-Jones JE, Misiewicz JJ, Connell AM, et al. Prednisone as maintenance treatment for ulcerative colitis in remission. Lancet 1965;!: 188-9
9. Truelove SC, Witts LJ. Cortisone and corticotrophin in ulcerative colitis. BMJ 1959; I: 387-94
10. ] 0. Hawthorne AB, Record CO, Holdsworlh CD. et al. Double blind trial of oral fluticasone propionate versus prednisolone in the treatment of active ulcerative colitis. Gut 1993; 1: 125-8
11. Lofberg R, Danielsson A, Nilsson A, et al. Oral budesonide is comparable to prednisolone in active ulcerative colitis but causes no suppression of plasma cortisol - controlled pilot study [abstract]. Abstracts of the World Congress of Gastroenterology; 1994 September: Los Angeles
12. Truelove SC. Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium: report of a controlled therapeutic trial. BMJ 1958; 2: 1072-7
13. Danish Budesonide Study Group. Budesonide enema in distal ulcerative colitis: a randomised dose-response trial with prednisolone enema as positive control. Scand J Gastroentero) 1991:26(12); 1225-30
14. Mulder C, Fockens P, Van der et al. A controlled randomized trial of beclomethasone (3 mg) versus 5-aminosalicylic acid ( 1 g) versus the combination of both (3 mg/1 g) as retention enemas in active distal ulcerative colitis [abstract], Gastroenterology 1994; 106: A739
15. Summers RW, Switz DM, Sessions JT, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-69
16. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-66
17. Shepherd H, Barr G, Jewell D. Use of intravenous steroid regimen in the treatment of acute Crohn's disease. J Clin Gastroenterol 1986; 8: 154-9
18. Carpani de Kaski M, Hodgson HJ. Fluticasone propionate in inflammatory bowel disease. Can J Gastroenterol 1990; 4 (7): 417-9
19. Greenberg GR, Feagan BG, Martin F. et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994; .331: 836-41
20. Rutgeerts P, Lofberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Eng! J Med 1994; 331: 842-5
21. Lofberg R, Rutgeerts P, Malchow H, el al. Budesonide C1R for maintenance of remission in ileocecal Crohn's disease: a European multicentre placebo-controlled trial for 12 months [abstract]. Gastroenterology 1994; 106: A724
22. Modigliani R, Mary J Y, Simon JF, et al. Clinical, biological and endoscopie picture of attacks of Crohn's disease: evolution on prednisone. Gastroenterology 1990; 98: 811-8
23. Lochs H, Steinhardt J, Klaus-Wentz B, et al. Comparison of enterai nutrition and drug treatment in active Crohn's disease. Gastroenterology 1991; 101: 881-8
24. Compston JE, Judd D. Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410-5
25. Chamberlin P, Meyer WJ. Management of pituitary-adrenal suppression secondary to corticosteroid therapy. Pediatrics 1981:67:245-51
26. Barocco BJ, Korelitz Bl. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. Gastroenterol 1984; 6: 211
27. Correspondence and reprints: Dr Paul}. Rutgeerts, Department of Gastroenterology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.